Work

Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer

Year: 2016

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2016.11.043

Authors: Fernanda Musa, Bhavana Pothuri, Stephanie V. Blank, Huichung T. Ling, James L. Speyer, John Curtin, Leslie Boyd, Xiaochun Li, Judith D. Goldberg, Franco Muggia, Amy Tiersten

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559839581

FWCI: 4.87

Cites: 26

Cited by: 31

Related to: 10